About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia

NCT01972178·29 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pronova BioPharma

6-8 weeks screening period with diet/lifestyle stabilization and lipid qualification

Age

18–79

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Fasting triglycerides 200-499 mg/dl
Non-HDL-C \> 130 mg/dl
Stable statin treatment

You may not be if

Type I diabetes or uncontrolled type II diabetes
Recent cardiovascular or coronary event
History of pancreatitis
History or evidence of major and clinically significant diseases that would interfere with the conduct of the study or interpretation of data
Uncontrolled hypertension

The record

StatusTerminated

PhasePhase 2

Taking part113

StartedNov 2013

UpdatedOct 30, 2015

Conditions

Where29

Medical Affiliated Research Center, Inc.
Huntsville, Alabama, United States
Terence Hart, MD
Muscle Shoals, Alabama, United States
Pacific Oaks Medical Group
Beverly Hills, California, United States

Clareo Health | Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia